APTUS Heli-FX® HA-18-114Recalls & reported problems
Medtronic Vascular, Inc. · ACC HA-18-114 TAA APP-CASSETTE 10 MDT · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169647602), received between Apr 7, 2017 and Apr 7, 2017 — classified as 1 injury.
The most frequently reported specific device problem is “Leak/Splash” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Leak/Splash1
Patient problems
- Renal Failure1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryApr 7, 2017Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem
AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 6.8 CM ABDOMINAL AORTIC ANEURYSM. DIAMETER OF THE NECK BELOW THE LOWEST RENAL ARTERY WAS 29MM AND THE LENGTH OF THE NECK WAS 49MM. IT WAS REPORTED THAT A TYPE IA ENDOLEAK WAS SEEN, AND A CHIMNEY PROCEDURE WAS PERFORMED IN THE LEFT RENAL USING ANOTHER MANUFACTURER¿S STENT AND AN ENDURANT AORTIC CUFF. IMAGING SHOWED EVIDENCE OF A RESIDUAL PROXIMAL TYPE I ENDOLEAK AT THE RIGHT LATERAL ASPECT OF THE AORTIC CUFF AND THE PHYSICIAN ELECTED TO IMPLANT FOR HELI-FX ENDOANCHORS. THE FINAL ANGIOGRAM REVEALED A VERY LATE PROXIMAL TYPE I ENDOLEAK AND WAS DETERMINED BY THE PHYSICIAN TO BE UNREMARKABLE SINCE THE SUBJECT WAS FULLY HEPARINIZED. THE PROCEDURE WAS COMPLETED WITH THE PATIENT SCHEDULED FOR NORMAL FOLLOW UP. ON THE DAY FOLLOWING THE PROCEDURE TO IMPLANT THE ENDOANCHORS, THE PATIENT DEVELOPED ACUTE KIDNEY INJURY. HYDRATION WAS ADMINISTERED AND THE EVENT IS CONTINUING BUT THE PATIENT WAS DISCHARGED. THE PHYSICIAN INVESTIGATOR ASSESSED THIS TO BE RELATED TO THE PROCEDURE. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS BEING MONITORED BY THE PHYSICIAN.
Patient problems: Renal Failure
MAUDE report 6474103 ↗
Other Endovascular suturing system devices
- Heli-FX™ EndoAnchor™ System SA-85Medtronic, Inc. · Endovascular suturing system6 deaths70 reports
- Heli-FX™ EndoAnchor™ System HG-18-90-22Medtronic, Inc. · Endovascular suturing system1 recall1 report
- Heli-FX™ EndoAnchor™ System HG-18-90-42Medtronic, Inc. · Endovascular suturing system1 recall0 reports
- APTUS Heli-FX® SA-85Medtronic, Inc. · Endovascular suturing system8 deaths50 reports
- Heli-FX™ EndoAnchor™ System SA-85Medtronic, Inc. · Endovascular suturing system4 deaths44 reports
- Heli-FX™ EndoAnchor™ System SA-85Medtronic, Inc. · Endovascular suturing system6 deaths41 reports
- Heli-FX™ EndoAnchor™ System SG-64Medtronic, Inc. · Endovascular suturing system18 reports
- APTUS Heli-FX® HG-16-62-28Medtronic Vascular, Inc. · Endovascular suturing system6 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page